Arcus Biosciences, Inc. (RCUS)
NYSE · Manufacturing · Pharmaceutical preparations
$24.37−$0.6892 (−2.75%) on the dayAs of the close; data may be delayed.
RCUS price, last 12 months
Key stats
- Previous close
- $25.06
- Open
- $25.60
- Day range
- $24.34 – $25.60
- 52-week range
- $12.15 – $31.74
- Volume
- 1.5M
- Avg volume (20 days)
- 1.7M
- Market cap
- $3.2B
Performance
1W−3.4%
1M−20.8%
3M−21.4%
6M+14.9%
YTD+2.3%
1Y+94.8%
vs S&P 500, 1Y+78.0 pts
Technicals and fundamentals
About Arcus Biosciences, Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $3.2B